Table 5.
Univariate analysis of the efficacy assessment after two sessions of HMME-PDT.
| Independent variables | Effective | Non-effective | z/χ2 | P | |
|---|---|---|---|---|---|
| n (%) | n (%) | ||||
| Age | −2.977 | 0.003 | |||
| Sex | 0.471 | 0.492 | |||
| Male | 91 (79.8%) | 23 (20.2%) | |||
| Female | 81 (83.5%) | 16 (16.5%) | |||
| Lesion distribution | 6.530 | 0.088 | |||
| Middle face | 52 (78.8%) | 14 (21.2%) | |||
| Lateral face | 42 (93.3%) | 3 (6.7%) | |||
| Neck | 5 (71.4%) | 2 (28.6%) | |||
| Mixed parts | 73 (78.5%) | 20 (21.5%) | |||
| Treatment history | 10.238 | 0.006 | |||
| None | 86 (89.6%) | 10 (10.4%) | |||
| Effective treatment group | 43 (69.4%) | 19 (30.6%) | |||
| Ineffective treatment group | 43 (81.1%) | 10 (18.9%) |